Income Tax Expense (Benefit) of Merck & Co., Inc. from 31 Mar 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Merck & Co., Inc. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 31 Mar 2010 to 31 Dec 2025.
  • Merck & Co., Inc. Income Tax Expense (Benefit) for the quarter ending 31 Dec 2025 was $457,000,000, a 7.3% increase year-over-year.
  • Merck & Co., Inc. Income Tax Expense (Benefit) for the twelve months ending 31 Dec 2025 was $2,804,000,000, a 0.04% increase year-over-year.
  • Merck & Co., Inc. annual Income Tax Expense (Benefit) for 2025 was $2,804,000,000, a 0.04% increase from 2024.
  • Merck & Co., Inc. annual Income Tax Expense (Benefit) for 2024 was $2,803,000,000, a 85% increase from 2023.
  • Merck & Co., Inc. annual Income Tax Expense (Benefit) for 2023 was $1,512,000,000, a 21% decline from 2022.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

Merck & Co., Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $2,804,000,000 $457,000,000 +$31,000,000 +7.3% 01 Oct 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 $2,773,000,000 $958,000,000 +$29,000,000 +3.1% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $2,744,000,000 $571,000,000 +$26,000,000 +4.8% 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $2,718,000,000 $818,000,000 -$85,000,000 -9.4% 01 Jan 2025 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q4 2024 $2,803,000,000 $426,000,000 +$1,246,000,000 01 Oct 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 $1,557,000,000 $929,000,000 +$59,000,000 +6.8% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 $1,498,000,000 $545,000,000 -$92,000,000 -14% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025 2025 Q2
Q1 2024 $1,590,000,000 $903,000,000 +$78,000,000 +9.5% 01 Jan 2024 31 Mar 2024 10-Q 02 May 2025 2025 Q1
Q4 2023 $1,512,000,000 $820,000,000 -$1,316,000,000 -265% 01 Oct 2023 31 Dec 2023 10-K 24 Feb 2026 2025 FY
Q3 2023 $2,828,000,000 $870,000,000 +$540,000,000 +164% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 $2,288,000,000 $637,000,000 +$99,000,000 +18% 01 Apr 2023 30 Jun 2023 10-Q 05 Aug 2024 2024 Q2
Q1 2023 $2,189,000,000 $825,000,000 +$271,000,000 +49% 01 Jan 2023 31 Mar 2023 10-Q 03 May 2024 2024 Q1
Q4 2022 $1,918,000,000 $496,000,000 +$411,000,000 +484% 01 Oct 2022 31 Dec 2022 10-K 25 Feb 2025 2024 FY
Q3 2022 $1,507,000,000 $330,000,000 -$365,000,000 -53% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023 2023 Q3
Q2 2022 $1,872,000,000 $538,000,000 +$35,000,000 +7% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023 2023 Q2
Q1 2022 $1,837,000,000 $554,000,000 +$316,000,000 +133% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023 2023 Q1
Q4 2021 $1,521,000,000 $85,000,000 +$140,000,000 01 Oct 2021 31 Dec 2021 10-K 26 Feb 2024 2023 FY
Q3 2021 $1,381,000,000 $695,000,000 +$315,000,000 +83% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $1,066,000,000 $503,000,000 +$107,000,000 +27% 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2022 2022 Q2
Q1 2021 $959,000,000 $238,000,000 -$381,000,000 -62% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q4 2020 $1,340,000,000 $55,000,000 -$360,000,000 -118% 01 Oct 2020 31 Dec 2020 10-K 24 Feb 2023 2022 FY
Q3 2020 $1,700,000,000 $380,000,000 -$60,000,000 -14% 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2021 2021 Q3
Q2 2020 $1,760,000,000 $396,000,000 -$219,000,000 -36% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q2
Q1 2020 $1,979,000,000 $619,000,000 +$414,000,000 +202% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q4 2019 $1,565,000,000 $305,000,000 -$522,000,000 -63% 01 Oct 2019 31 Dec 2019 10-K 25 Feb 2022 2021 FY
Q3 2019 $2,087,000,000 $440,000,000 -$267,000,000 -38% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3
Q2 2019 $2,354,000,000 $615,000,000 +$245,000,000 +66% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020 2020 Q2
Q1 2019 $2,109,000,000 $205,000,000 -$399,000,000 -66% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q4 2018 $2,508,000,000 $827,000,000 -$2,090,000,000 -72% 01 Oct 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
Q3 2018 $4,598,000,000 $707,000,000 +$456,000,000 +182% 01 Jul 2018 30 Sep 2018 10-Q 05 Nov 2019 2019 Q3
Q2 2018 $4,142,000,000 $370,000,000 -$118,000,000 -24% 01 Apr 2018 30 Jun 2018 10-Q 06 Aug 2019 2019 Q2
Q1 2018 $4,260,000,000 $604,000,000 +$157,000,000 +35% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q4 2017 $4,103,000,000 $2,917,000,000 +$3,687,000,000 01 Oct 2017 31 Dec 2017 10-K 26 Feb 2020 2019 FY
Q3 2017 $416,000,000 $251,000,000 -$448,000,000 -64% 01 Jul 2017 30 Sep 2017 10-Q 06 Nov 2018 2018 Q3
Q2 2017 $864,000,000 $488,000,000 +$193,000,000 +65% 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2018 2018 Q2
Q1 2017 $671,000,000 $447,000,000 -$47,000,000 -9.5% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018 2018 Q1
Q4 2016 $718,000,000 $770,000,000 -$604,000,000 -364% 01 Oct 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
Q3 2016 $1,322,000,000 $699,000,000 +$133,000,000 +23% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2017 2017 Q3
Q2 2016 $1,189,000,000 $295,000,000 +$176,000,000 +148% 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2017 2017 Q2
Q1 2016 $1,013,000,000 $494,000,000 +$71,000,000 +17% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q4 2015 $942,000,000 $166,000,000 -$4,649,000,000 -104% 01 Oct 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
Q3 2015 $5,591,000,000 $566,000,000 -$82,000,000 -13% 01 Jul 2015 30 Sep 2015 10-Q 07 Nov 2016 2016 Q3
Q2 2015 $5,673,000,000 $119,000,000 +$261,000,000 01 Apr 2015 30 Jun 2015 10-Q 08 Aug 2016 2016 Q2
Q1 2015 $5,412,000,000 $423,000,000 +$63,000,000 +18% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q1
Q4 2014 $5,349,000,000 $4,483,000,000 +$4,074,000,000 +996% 01 Oct 2014 31 Dec 2014 10-K 28 Feb 2017 2016 FY
Q3 2014 $1,275,000,000 $648,000,000 +$273,000,000 +73% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015 2015 Q3
Q2 2014 $1,002,000,000 $142,000,000 -$452,000,000 -146% 01 Apr 2014 30 Jun 2014 10-Q 06 Aug 2015 2015 Q2
Q1 2014 $1,454,000,000 $360,000,000 +$426,000,000 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015 2015 Q1
Q4 2013 $1,028,000,000 $409,000,000 +$24,000,000 +6.2% 01 Oct 2013 31 Dec 2013 10-K 26 Feb 2016 2015 FY
Q3 2013 $1,004,000,000 $375,000,000 -$80,000,000 -18% 01 Jul 2013 30 Sep 2013 10-Q 10 Nov 2014 2014 Q3
Q2 2013 $1,084,000,000 $310,000,000 -$550,000,000 -64% 01 Apr 2013 30 Jun 2013 10-Q 07 Aug 2014 2014 Q2
Q1 2013 $1,634,000,000 $66,000,000 -$806,000,000 -109% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014 2014 Q1
Q4 2012 $2,440,000,000 $385,000,000 +$347,000,000 +913% 01 Oct 2012 31 Dec 2012 10-K 27 Feb 2015 2014 FY
Q3 2012 $2,093,000,000 $455,000,000 -$173,000,000 -28% 01 Jul 2012 30 Sep 2012 10-Q 07 Nov 2013 2013 Q3
Q2 2012 $2,266,000,000 $860,000,000 +$1,242,000,000 01 Apr 2012 30 Jun 2012 10-Q 07 Aug 2013 2013 Q2
Q1 2012 $1,024,000,000 $740,000,000 +$82,000,000 +12% 01 Jan 2012 31 Mar 2012 10-Q 09 May 2013 2013 Q1
Q4 2011 $942,000,000 $38,000,000 +$240,000,000 01 Oct 2011 31 Dec 2011 10-K 27 Feb 2014 2013 FY
Q3 2011 $702,000,000 $628,000,000 +$502,000,000 +398% 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012 2012 Q3
Q2 2011 $200,000,000 $382,000,000 -$843,000,000 -183% 01 Apr 2011 30 Jun 2011 10-Q 07 Aug 2012 2012 Q2
Q1 2011 $1,043,000,000 $658,000,000 +$372,000,000 +130% 01 Jan 2011 31 Mar 2011 10-Q 08 May 2012 2012 Q1
Q4 2010 $671,000,000 $202,000,000 01 Oct 2010 31 Dec 2010 10-K 28 Feb 2013 2012 FY
Q3 2010 $126,000,000 01 Jul 2010 30 Sep 2010 10-Q 08 Nov 2011 2011 Q3
Q2 2010 $461,000,000 01 Apr 2010 30 Jun 2010 10-Q 08 Aug 2011 2011 Q2
Q1 2010 $286,000,000 01 Jan 2010 31 Mar 2010 10-Q 09 May 2011 2011 Q1

Merck & Co., Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $2,804,000,000 +$1,000,000 +0.04% 01 Jan 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
2024 $2,803,000,000 +$1,291,000,000 +85% 01 Jan 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
2023 $1,512,000,000 -$406,000,000 -21% 01 Jan 2023 31 Dec 2023 10-K 24 Feb 2026 2025 FY
2022 $1,918,000,000 +$397,000,000 +26% 01 Jan 2022 31 Dec 2022 10-K 25 Feb 2025 2024 FY
2021 $1,521,000,000 +$181,000,000 +14% 01 Jan 2021 31 Dec 2021 10-K 26 Feb 2024 2023 FY
2020 $1,340,000,000 -$225,000,000 -14% 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2023 2022 FY
2019 $1,565,000,000 -$943,000,000 -38% 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2022 2021 FY
2018 $2,508,000,000 -$1,595,000,000 -39% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $4,103,000,000 +$3,385,000,000 +471% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020 2019 FY
2016 $718,000,000 -$224,000,000 -24% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
2015 $942,000,000 -$4,407,000,000 -82% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
2014 $5,349,000,000 +$4,321,000,000 +420% 01 Jan 2014 31 Dec 2014 10-K 28 Feb 2017 2016 FY
2013 $1,028,000,000 -$1,412,000,000 -58% 01 Jan 2013 31 Dec 2013 10-K 26 Feb 2016 2015 FY
2012 $2,440,000,000 +$1,498,000,000 +159% 01 Jan 2012 31 Dec 2012 10-K 27 Feb 2015 2014 FY
2011 $942,000,000 +$271,000,000 +40% 01 Jan 2011 31 Dec 2011 10-K 27 Feb 2014 2013 FY
2010 $671,000,000 01 Jan 2010 31 Dec 2010 10-K 28 Feb 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.